Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 151 No. 0506 (2021)

Association of in-hospital multimorbidity with healthcare outcomes in Swiss medical inpatients

DOI
https://doi.org/10.4414/smw.2021.20405
Cite this as:
Swiss Med Wkly. 2021;151:w20405
Published
05.02.2021

Summary

IMPORTANCE: Multimorbidity poses a worldwide health- and socio-economic challenge, exacerbated by changing demographics. The association of multimorbidity with healthcare outcomes in hospitalised medical inpatients remains incompletely understood.

OBJECTIVE: To examine the prevalence and burden of in-hospital multimorbidity over a 6-year time period and its association with in-hospital mortality, intensive care unit admission, length of hospital stay and readmission rates.

DESIGN: This cross-sectional study analysed Swiss hospital discharge records from 1 January 2012 to 31 December 2017.

SETTING: The study used population-based, administrative data from the Swiss Federal Statistical Office to investigate all adult medical cases in Switzerland.

PARTICIPANTS: 2,220,000 population-based medical discharge records from 1,463,781 anonymised patients were included in the analysis. Multimorbidity was defined according to the World Health Organization as the presence of at least two chronic conditions. We applied the “Chronic Condition Indicator for the International Classification of Diseases (ICD-10-CM)”, which divides all ICD-10 codes into chronic and acute conditions, to define the number of chronic conditions.

MAIN MEASURES: Time- and age-stratified prevalence of multimorbidity and its association with in-hospital mortality, ICU admission rate, length of stay, 30-day and 1-year all-cause readmission rates.

RESULTS: Of the 2,220,000 cases, 51.3% were male with a mean age of 68.0 years (standard deviation 17.4). A total of 1,769,530 (79.7%) were multimorbid with a median of 4 (interquartile range 2–6) chronic conditions. The prevalence of multimorbidity increased by about 1.0% per year over the 6-year study period from 76.1% (2012) to 82.2% (2017). Multimorbidity was associated with higher odds of in-hospital mortality (odds ratio [OR] 1.31, 95% confidence interval [CI] 1.28 to 1.34), ICU admission rate (OR 3.29, 95% CI 3.23 to 3.34), length of stay (+2.7 days, 95% CI 2.6 to 2.7), 30-day- (OR 1.92, 95% CI 1.89 to 1.94) and 1-year all-cause readmission rates (OR 1.70, 95% CI 1.68 to 1.71). The associations with in-hospital mortality and readmission were strongest in younger patients.

CONCLUSIONS: Multimorbidity is highly prevalent in medical inpatients and has a relevant association with poor healthcare outcomes. Further investigation is needed to specify risk factors as well as to optimise the management of multimorbid patients to improve outcomes.

References

  1. Thorpe KE, Ogden LL, Galactionova K. Chronic conditions account for rise in Medicare spending from 1987 to 2006. Health Aff (Millwood). 2010;29(4):718–24. doi:.https://doi.org/10.1377/hlthaff.2009.0474
  2. Cassell A, Edwards D, Harshfield A, Rhodes K, Brimicombe J, Payne R, et al. The epidemiology of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2018;68(669):e245–51. doi:.https://doi.org/10.3399/bjgp18X695465
  3. Salive ME. Multimorbidity in older adults. Epidemiol Rev. 2013;35(1):75–83. doi:.https://doi.org/10.1093/epirev/mxs009
  4. Kernick D, Chew-Graham CA, O’Flynn N. Clinical assessment and management of multimorbidity: NICE guideline. Br J Gen Pract. 2017;67(658):235–6. doi:.https://doi.org/10.3399/bjgp17X690857
  5. Kingston A, Robinson L, Booth H, Knapp M, Jagger C ; MODEM project. Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model. Age Ageing. 2018;47(3):374–80. doi:.https://doi.org/10.1093/ageing/afx201
  6. World Health Organization. World Health Report 2008: Primary health care: Now more than ever. Geneva: World Health Organization; 2008.
  7. National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and management. Published September 2016. Available from: https://www.nice.org.uk/guidance/ng56/chapter/Recommendations.
  8. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43. doi:.https://doi.org/10.1016/S0140-6736(12)60240-2
  9. Parekh AK, Goodman RA. The HHS Strategic Framework on multiple chronic conditions: genesis and focus on research. J Comorb. 2013;3(2):22–9. doi:.https://doi.org/10.15256/joc.2013.3.20
  10. Lewis C, Wallace E, Kyne L, Cullen W, Smith SM. Training doctors to manage patients with multimorbidity: a systematic review. J Comorb. 2016;6(2):85–94. doi:.https://doi.org/10.15256/joc.2016.6.87
  11. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357–63.
  12. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–76. doi:.https://doi.org/10.1001/archinte.162.20.2269
  13. Vogeli C, Shields AE, Lee TA, Gibson TB, Marder WD, Weiss KB, et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med. 2007;22(S3, Suppl 3):391–5. doi:.https://doi.org/10.1007/s11606-007-0322-1
  14. Healthcare Cost and Utilization Project. Chronic Condition Indicator (CCI) for ICD-10-CM (beta version). 2018. Available from: www.hcup-us.ahrq.gov/toolssoftware/chronic_icd10/chronic_icd10.jsp
  15. Schneider F, Kaplan V, Rodak R, Battegay E, Holzer B. Prevalence of multimorbidity in medical inpatients. Swiss Med Wkly. 2012;142:w13533.
  16. Switzerland Federal Statistical Office. Die Bevölkerung der Schweiz 2017. Available from: https://www.bfs.admin.ch/bfs/en/home/statistics/population/effectif-change.assetdetail.6606496.html. Accessed 2020 April 21.
  17. Aubert CE, Fankhauser N, Marques-Vidal P, Stirnemann J, Aujesky D, Limacher A, et al. Patterns of multimorbidity in internal medicine patients in Swiss university hospitals: a multicentre cohort study. Swiss Med Wkly. 2019;149:w20094. doi:.https://doi.org/10.4414/smw.2019.20094
  18. Clerencia-Sierra M, Calderón-Larrañaga A, Martínez-Velilla N, Vergara-Mitxeltorena I, Aldaz-Herce P, Poblador-Plou B, et al. Multimorbidity Patterns in Hospitalized Older Patients: Associations among Chronic Diseases and Geriatric Syndromes. PLoS One. 2015;10(7):e0132909.
  19. Agborsangaya CB, Ngwakongnwi E, Lahtinen M, Cooke T, Johnson JA. Multimorbidity prevalence in the general population: the role of obesity in chronic disease clustering. BMC Public Health. 2013;13(1):1161. doi:.https://doi.org/10.1186/1471-2458-13-1161
  20. Fitzgerald G, Gallagher P, O’Shea F. Multimorbidity is Common in Axial Spondyloarthropathy and is Associated with Worse Disease Outcomes: Results from the ASRI cohort. J Rheumatol. 2020;47(2):218–26. doi:. https://doi.org/10.3899/jrheum.181415
  21. McDaid O, Hanly MJ, Richardson K, Kee F, Kenny RA, Savva GM. The effect of multiple chronic conditions on self-rated health, disability and quality of life among the older populations of Northern Ireland and the Republic of Ireland: a comparison of two nationally representative cross-sectional surveys. BMJ Open. 2013;3(6):e002571. doi:.https://doi.org/10.1136/bmjopen-2013-002571
  22. Stanley J, Semper K, Millar E, Sarfati D. Epidemiology of multimorbidity in New Zealand: a cross-sectional study using national-level hospital and pharmaceutical data. BMJ Open. 2018;8(5):e021689. doi:.https://doi.org/10.1136/bmjopen-2018-021689
  23. Excoffier S, Herzig L, N’Goran AA, Déruaz-Luyet A, Haller DM. Prevalence of multimorbidity in general practice: a cross-sectional study within the Swiss Sentinel Surveillance System (Sentinella). BMJ Open. 2018;8(3):e019616. doi:.https://doi.org/10.1136/bmjopen-2017-019616
  24. Hu RH, Hsiao FY, Chen LJ, Huang PT, Hsu WW. Increasing age- and gender-specific burden and complexity of multimorbidity in Taiwan, 2003-2013: a cross-sectional study based on nationwide claims data. BMJ Open. 2019;9(6):e028333. doi:.https://doi.org/10.1136/bmjopen-2018-028333
  25. Nicholson K, Terry AL, Fortin M, Williamson T, Bauer M, Thind A. Prevalence, characteristics, and patterns of patients with multimorbidity in primary care: a retrospective cohort analysis in Canada. Br J Gen Pract. 2019;69(686):e647–56. doi:.https://doi.org/10.3399/bjgp19X704657
  26. Bähler C, Huber CA, Brüngger B, Reich O. Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study. BMC Health Serv Res. 2015;15(1):23. doi:.https://doi.org/10.1186/s12913-015-0698-2
  27. van Oostrom SH, Gijssen R, Stirbu I, Korevaar JC, Schellevis FG, Picavet HSJ, et al. [Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys]. Ned Tijdschr Geneeskd. Article in Dutch. 2017;161:D1429.
  28. Lebenbaum M, Zaric GS, Thind A, Sarma S. Trends in obesity and multimorbidity in Canada. Prev Med. 2018;116:173–9. doi:.https://doi.org/10.1016/j.ypmed.2018.08.025
  29. Koné Pefoyo AJ, Bronskill SE, Gruneir A, Calzavara A, Thavorn K, Petrosyan Y, et al. The increasing burden and complexity of multimorbidity. BMC Public Health. 2015;15(1):415. doi:.https://doi.org/10.1186/s12889-015-1733-2
  30. Tetzlaff J, Muschik D, Epping J, Eberhard S, Geyer S. Expansion or compression of multimorbidity? 10-year development of life years spent in multimorbidity based on health insurance claims data of Lower Saxony, Germany. Int J Public Health. 2017;62(6):679–86. doi:.https://doi.org/10.1007/s00038-017-0962-9
  31. Feely A, Lix LM, Reimer K. Estimating multimorbidity prevalence with the Canadian Chronic Disease Surveillance System. Health Promot Chronic Dis Prev Can. 2017;37(7):215–22. doi:.https://doi.org/10.24095/hpcdp.37.7.02
  32. Kutz A, Gut L, Ebrahimi F, Wagner U, Schuetz P, Mueller B. Association of the Swiss Diagnosis-Related Group Reimbursement System With Length of Stay, Mortality, and Readmission Rates in Hospitalized Adult Patients. JAMA Netw Open. 2019;2(2):e188332. doi:.https://doi.org/10.1001/jamanetworkopen.2018.8332
  33. Kaur P, Saxena N, You AX, Wong RCC, Lim CP, Loh SY, et al. Effect of multimorbidity on survival of patients diagnosed with heart failure: a retrospective cohort study in Singapore. BMJ Open. 2018;8(5):e021291. doi:.https://doi.org/10.1136/bmjopen-2017-021291
  34. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. doi:.https://doi.org/10.1016/0021-9681(87)90171-8
  35. Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data: The AHRQ Elixhauser Comorbidity Index. Med Care. 2017;55(7):698–705. doi:.https://doi.org/10.1097/MLR.0000000000000735
  36. Fischer S, Bosshard G, Zellweger U, Faisst K. Der Sterbeort: ?Wo sterben die Menschen heute in der Schweiz?? [Place of death: “Where do people die in Switzerland nowadays?”]. Z Gerontol Geriatr. 2004;37(6):467–74. Article in German. doi:.https://doi.org/10.1007/s00391-004-0216-3
  37. Murphy TE, Han L, Allore HG, Peduzzi PN, Gill TM, Lin H. Treatment of death in the analysis of longitudinal studies of gerontological outcomes. J Gerontol A Biol Sci Med Sci. 2011;66A(1):109–14. doi:.https://doi.org/10.1093/gerona/glq188
  38. Halonen P, Raitanen J, Jämsen E, Enroth L, Jylhä M. Chronic conditions and multimorbidity in population aged 90 years and over: associations with mortality and long-term care admission. Age Ageing. 2019;48(4):564–70. doi:.https://doi.org/10.1093/ageing/afz019
  39. Singh K, Patel SA, Biswas S, Shivashankar R, Kondal D, Ajay VS, et al. Multimorbidity in South Asian adults: prevalence, risk factors and mortality. J Public Health (Oxf). 2019;41(1):80–9. doi:.https://doi.org/10.1093/pubmed/fdy017
  40. Jani BD, Hanlon P, Nicholl BI, McQueenie R, Gallacher KI, Lee D, et al. Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort. BMC Med. 2019;17(1):74. doi:.https://doi.org/10.1186/s12916-019-1305-x
  41. Ryan BL, Allen B, Zwarenstein M, Stewart M, Glazier RH, Fortin M, et al. Multimorbidity and mortality in Ontario, Canada: A population-based retrospective cohort study. J Comorb. 2020;10:2235042X2095059. doi:.https://doi.org/10.1177/2235042X20950598
  42. Aubert CE, Schnipper JL, Fankhauser N, Marques-Vidal P, Stirnemann J, Auerbach AD, et al. Patterns of multimorbidity associated with 30-day readmission: a multinational study. BMC Public Health. 2019;19(1):738. doi:.https://doi.org/10.1186/s12889-019-7066-9
  43. Librero J, Peiró S, Ordiñana R. Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. J Clin Epidemiol. 1999;52(3):171–9. doi:.https://doi.org/10.1016/S0895-4356(98)00160-7
  44. Beeler PE, Cheetham M, Held U, Battegay E. Depression is independently associated with increased length of stay and readmissions in multimorbid inpatients. Eur J Intern Med. 2020;73:59–66. doi:.https://doi.org/10.1016/j.ejim.2019.11.012
  45. Kutz A, Koch D, Conca A, Baechli C, Haubitz S, Regez K, et al. Integrative hospital treatment in older patients to benchmark and improve outcome and length of stay - the In-HospiTOOL study. BMC Health Serv Res. 2019;19(1):237. doi:.https://doi.org/10.1186/s12913-019-4045-x

Most read articles by the same author(s)

1 2 3 > >>